Are Polynucleotides Better Than Botox? Fine Lines, Skin Quality, and Expression Wrinkles

Author: Dr Nyla Raja
Date Last Modified: 19 October, 2026
Patient undergoing polynucleotide treatment for skin rejuvenation at Dr Nyla Medispa in Mayfair, London

Clinical guidance from Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology - GMC No. 6057913

No. Polynucleotides are not universally better than Botox, and Botox is not automatically the better choice for every line. They work in different ways: polynucleotides are used to support hydration, texture, elasticity, and overall skin quality, while Botox temporarily reduces movement in selected muscles to soften expression wrinkles.

The useful question is not which treatment is “better”, but what is causing the concern. Fine, crepey skin, dehydration, and delicate under-eye skin may be better aligned with polynucleotides. Forehead lines that deepen when you raise your eyebrows, frown lines, and crow’s feet that appear with smiling are more likely to respond to Botox.

Polynucleotides vs Botox: the essential difference

Facial lines do not all form for the same reason. Some are driven mainly by repeated muscle movement. Others become more visible because the skin is thinner, less hydrated, or has lost some elasticity. Many people have a combination of both.

Botox is a prescription-only botulinum toxin type A medicine. It works locally at the connection between a nerve and a treated muscle, temporarily reducing the strength of muscle contraction. This makes it particularly suitable for dynamic lines: wrinkles that form or deepen with expression. The Summary of Product Characteristics for BOTOX sets out its approved uses, contraindications, precautions, and recognised side effects.

Polynucleotides are non-surgical injectable treatments made from highly purified DNA fragments. They do not relax facial muscles, add volume, or reshape the face. Instead, they are used to support visible skin quality progressively. That makes them more relevant where the goal is smoother-looking, better-hydrated, more resilient skin, rather than reducing the movement that creates a line.

Concern May be more suitable Why
Frown lines, forehead lines, crow’s feet that appear with expression Botox Targets selected muscles causing repeated movement.
Crepey texture, dehydration, fine superficial lines, reduced elasticity Polynucleotides Focuses on gradual skin-quality improvement.
Thin, fragile-looking under-eye skin Polynucleotides may be considered They do not create volume and may be considered for delicate areas following assessment.
Lines visible at rest as well as with expression Assessment is needed Muscle movement, skin quality, sun damage, and facial structure may all contribute.

Which treatment is more effective for fine lines?

It depends on the type of fine line.

Botox may be more effective when fine lines are mainly caused by movement. For example, a line that appears strongly between the brows when frowning is unlikely to improve substantially with a skin-quality treatment alone, because the underlying muscle activity remains unchanged.

Polynucleotides may be more appropriate when fine lines are linked to dryness, crepiness, reduced elasticity, or a generally tired-looking skin texture. Results are intended to be subtle and progressive, rather than immediate or structural. They are not designed to erase deeper folds or replace lost volume.

Research into polynucleotides in aesthetic medicine is promising, but still developing. A systematic review of nine clinical studies reported improvements in wrinkles, texture, and elasticity, but also found that the evidence base was small and that protocols varied. This is important: polynucleotides can be a useful option for the right concern, but expectations should remain realistic.

How quickly do polynucleotides and Botox work?

Botox and polynucleotides have very different timelines.

  • Botox: early changes often develop within a few days, with the full effect usually visible after 7–14 days. Results commonly last around three to six months, although this varies by area, muscle activity, dose, and individual response.
  • Polynucleotides: early improvements in hydration, softness, and radiance may become noticeable over the first few weeks. More meaningful changes in firmness, elasticity, and skin quality may develop over two to three months. An initial course, often involving two or three appointments spaced several weeks apart, may be appropriate depending on the product, area, and starting skin condition.

Neither treatment should be judged against filtered photographs or another person’s result. Individual anatomy, skin quality, lifestyle, medical history, and the treatment plan all affect the visible outcome.

Clinical Note from Dr Nyla Raja

At Dr Nyla Medispa, a doctor-led assessment considers the treatment area, skin quality, facial anatomy, medical history, and the change a patient hopes to achieve. This helps distinguish whether a line is primarily expression-related, skin-quality-related, or influenced by both factors, so treatment remains proportionate and natural-looking.

Can polynucleotides and Botox be used together?

They can sometimes be considered as part of the same wider plan because they address different concerns. Botox may reduce the repeated movement that creases the skin, while polynucleotides may support skin quality in an area where texture, fine superficial lines, or crepiness are also present.

Combination treatment is not necessary for everyone, and it should not be approached as a default package. Treatment may need to be deferred or may not be appropriate where there is an active skin infection, a relevant medical contraindication, pregnancy or breastfeeding, or where the proposed outcome is not achievable with injectables. The priority is to establish the main cause of the concern before adding treatments.

Safety and recovery: what should patients consider?

Both treatments involve injections, so temporary redness, swelling, tenderness, small injection marks, and bruising can occur. With polynucleotides, small raised areas at injection sites and temporary swelling, particularly around the eyes, may be visible initially. These effects should settle rather than become increasingly painful, red, or swollen.

For Botox, mild local reactions are usually short-lived. Unwanted effects related to muscle relaxation, such as asymmetry or a temporary eyelid or brow droop, are less common but should be discussed as part of informed consent. Appropriate treatment planning depends on detailed knowledge of facial anatomy, muscle balance, product choice, and dose.

Botox must be prescribed following an in-person clinical assessment. GMC guidance requires an appropriate physical examination before a doctor prescribes non-surgical cosmetic medicines such as Botox; it must not be prescribed remotely. For either treatment, tell your practitioner about medicines, allergies, previous injectable treatments, relevant medical conditions, and any current illness or inflammation in the intended treatment area.

What to ask at a consultation

  • Are my lines mainly present at rest, with expression, or both?
  • Is my main concern skin texture, hydration, muscle movement, volume loss, or a combination?
  • What level of improvement is realistic for my skin and anatomy?
  • Would one treatment be sufficient before considering a combination approach?
  • What is the expected treatment course, recovery period, and maintenance plan?

The key point

Polynucleotides are not better than Botox for expression wrinkles, and Botox is not a substitute for improving overall skin quality. Botox is generally the more direct treatment for movement-related forehead lines, frown lines, and crow’s feet. Polynucleotides may be better aligned with fine, crepey, dehydrated, or less elastic skin, including selected delicate areas.

When both muscle movement and skin quality contribute to the concern, a personalised, doctor-led assessment can establish whether one treatment, staged treatment, or a carefully planned combination is the most appropriate route.

Share this post:
Book Enquire

Need Guidance in Selecting the Most Appropriate Treatment?

Dr Nyla Raja, GMC-registered aesthetic doctor and Founder of Dr Nyla Medispa in London, Cheshire, and Liverpool.

About the Author

Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology is a GMC-registered doctor (GMC No. 6057913), a member of the British College of Aesthetic Medicine (BCAM) and the British Association of Cosmetic Doctors (BACD), and Founder and Medical Director of Dr Nyla Medispa. She has more than 20 years of clinical experience in aesthetic medicine, with an evidence-based approach focused on patient safety and natural-looking results.

Dr Nyla Medispa was named Lumenis Awards Finalist for Best Clinic London in 2026, Safety in Beauty Best Clinic London Finalist in 2026, Best Clinic for Beauty and Safety in 2020, and an Aesthetic Awards Finalist in 2026, while Dr Nyla was nominated for Tatler’s Best Non-Surgical Facelift in 2025.

Considering treatment? Book a free consultation at our clinics in Mayfair London, Alderley Edge Cheshire, or Crosby Liverpool, or call 0800 009 6661.

Date Published: 17 October, 2026